Appili Therapeutics Inc. (APLI) Fundamentals

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
SHARE INFORMATION
Market Cap$ 6.057.620
Shares Outstanding71.266.120
Float57.283.348
Percent Float80,38%
Short Interest161.253,00
Short Percent Float100,0%
Short Interest Ratio1,2538
Short Interest Date2022-04-30
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0,24
Latest Fiscal Date2021-03-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions-
Institutional Holdings Date-
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0,0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned13.982.772
TRADING INFO
52 Week High$ 1,14
52 Week Low$ 0,08
52 Week High Change$ -90,00
21 Day Moving Average$ 0,100952
21 Day Extended Moving Average$ 0,099123
50 Day Moving Average$ 0,1091
50 Day Extended Moving Average$ 0,110766
200 Day Moving Average$ 0,3623
200 Day Extended Moving Average$ 0,325799
10 Day Average Volume498.731
20 Day Average Volume341.913
30 Day Average Volume244.352
50 Day Average Volume185.501
Alpha-0.006719
Beta1.10154
Standard Deviation0.334579
R20.024595
7 Day Price Change$ -0,01
7 Day Percent Change-10,53%
21 Day Price Change$ -0,025
21 Day Percent Change-22,73%
30 Day Price Change$ -0,03
30 Day Percent Change-26,09%
Month to Date Price Change$ -0,025
Month to Date Percent Change-22,73%
Quarter to Date Price Change$ -0,035
Quarter to Date Percent Change-29,17%
180 Day Price Change$ -0,10
180 Day Percent Change-54,05%
200 Day Price Change$ -0,685
200 Day Percent Change-88,96%
Year to Date Price Change$ -0,03
Year to Date Percent Change-26,09%

Appili Therapeutics Inc. (APLI) Key Ratios

PROFITABILITY
EBIT Margin-1.890,5%
EBITDA Margin-1.889,6%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ 1.390.684
Revenue Per Share$ 0,019514
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-13,95
Total Debt To Equity0,17
Int Coverage-59,70
Current Ratio1,00
Leverage Ratio4,30
Quick Ratio1,00
Long Term Debt To Capital0,14
VALUATION MEASURES
PE Ratio-0,20
Enterprise Value$ -312.672
Price to Sales4,3559
Price to Free Cash-0,40
PE High Last 5 Years0,00
Price To Book1,40
Price To Cash Flow0,00
PE Low Last 5 Years0,00
Price to Tangible Book-13,95
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,60
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-162,75
Return on Equity-316,15
Return on Capital-251,50

Appili Therapeutics Inc. (APLI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOArmand Balboni
Emplyoees16
Last AuditUE
CIK0000000000
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressNo. 21-1344 Summer Street
Suite 415
Halifax, NS B3H 0A8
Websitehttps://www.appilitherapeutics.com
Facsimile+1 902 442-4651
Telephone+1 902 442-4655
Email-
Seu Histórico Recente
TSX
APLI
Appili The..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220520 17:34:16